Zi-Hao Qi

710 total citations
9 papers, 523 citations indexed

About

Zi-Hao Qi is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Zi-Hao Qi has authored 9 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Zi-Hao Qi's work include Pancreatic and Hepatic Oncology Research (8 papers), Neuroendocrine Tumor Research Advances (4 papers) and Cancer Genomics and Diagnostics (2 papers). Zi-Hao Qi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Neuroendocrine Tumor Research Advances (4 papers) and Cancer Genomics and Diagnostics (2 papers). Zi-Hao Qi collaborates with scholars based in China. Zi-Hao Qi's co-authors include Xianjun Yu, Liang Liu, Hua-Xiang Xu, Wen-Quan Wang, Chun-Tao Wu, Jin-Zhi Xu, Quan-Xing Ni, He-Li Gao, Shi-Rong Zhang and Wei Jin and has published in prestigious journals such as Current Medicinal Chemistry, Annals of Surgical Oncology and Surgery.

In The Last Decade

Zi-Hao Qi

9 papers receiving 518 citations

Peers

Zi-Hao Qi
Comparison fields: 5 of 68
  • Oncology 269
  • Molecular Biology 217
  • Cancer Research 168
  • Immunology 135
  • Pulmonary and Respiratory Medicine 78
Zehua Wang China
Elena Vagia United States
Touko Inao Japan
Raefa Abou Khouzam United Arab Emirates
Markus Bernhardt Germany
Xiangzhan Kong China
Fengqing Fu China
Chuan Lin China
Wuhua Zhou China
Zehua Wang China View profile →
Citations per field, relative to Zi-Hao Qi
Zi-Hao Qi · 1×
Citations per year, relative to Zi-Hao Qi
Zi-Hao Qi · 1×

Countries citing papers authored by Zi-Hao Qi

Since Specialization
Citations

This map shows the geographic impact of Zi-Hao Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi-Hao Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi-Hao Qi more than expected).

Fields of papers citing papers by Zi-Hao Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi-Hao Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi-Hao Qi. The network helps show where Zi-Hao Qi may publish in the future.

Co-authorship network of co-authors of Zi-Hao Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Zi-Hao Qi. A scholar is included among the top collaborators of Zi-Hao Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi-Hao Qi. Zi-Hao Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
# Title Journal Authors Indexed citations
1 The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysis Hepatobiliary & pancreatic diseases international He-Li Gao, Liang Liu et al. 50
2 Postoperative serum CA19-9, CEA and CA125 predicts the response to adjuvant chemoradiotherapy following radical resection in pancreatic adenocarcinoma Pancreatology Hua-Xiang Xu, Shuo Li et al. 19
3 Angiogenesis in pancreatic cancer: current research status and clinical implications Angiogenesis Shuo Li, Hua-Xiang Xu et al. 218
4 The Significance of Liquid Biopsy in Pancreatic Cancer Journal of Cancer Zi-Hao Qi, Hua-Xiang Xu et al. 39
5 Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma Annals of Surgical Oncology Huaxiang Xu, Shirong Zhang et al. 97
6 RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling International Journal of Oncology Zi-Hao Qi, Hua-Xiang Xu et al. 41
7 Neoadjuvant Therapy is Essential for Resectable Pancreatic Cancer Current Medicinal Chemistry Jin-Zhi Xu, Wen-Quan Wang et al. 10
8 Intrinsic Contact Between T and N Classifications in Resected Well–Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms Annals of Surgical Oncology Jin-Zhi Xu, Wen-Quan Wang et al. 6
9 Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma Surgery Hua-Xiang Xu, Liang Liu et al. 43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026